People | August 29, 2023
Bayer appoints Dr. Juergen Eckhardt as new Head of Pharmaceuticals Business Development & Licensing/Open Innovation
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
The campaign seeks to raise awareness about hypertension while emphasising the significance of managing blood pressure for a healthier lifestyle
Global Initiative on Digital Health launched at the G2O Health Minister’s Meeting
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
Subscribe To Our Newsletter & Stay Updated
